Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-040808
Filing Date
2021-10-20
Accepted
2021-10-20 17:49:59
Documents
1
Period of Report
2021-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4282
  Complete submission text file 0000899243-21-040808.txt   5757
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Piekos Brian (Reporting) CIK: 0001815308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 211335064

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations